XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income
Treasury Stock
Non-controlling Interests
Balance, beginning of period (in shares) at Sep. 30, 2023   9,990,778          
Balance, beginning of period at Sep. 30, 2023 $ 18,757 $ 5,079 $ 7,687 $ 6,160 $ 2,104 $ (2,286) $ 13
Increase (Decrease) in Stockholders' Equity              
Net (loss) earnings (2,212)     (2,436)     224
Foreign currency translation adjustments, net of taxes of $0 8       8    
Distributions to non-controlling interests (223)           (223)
Share-based compensation 111   111        
Issuance of common stock for restricted stock units vested (in shares)   37,312          
Issuance of common stock for restricted stock units vested 0 $ 19 (19)        
Retirement plans:              
Amortization of accumulated other comprehensive gain into net periodic benefit cost, net of taxes of $0 (43)       (43)    
Balance, end of period (in shares) at Mar. 31, 2024   10,028,090          
Balance, end of period at Mar. 31, 2024 16,398 $ 5,098 7,779 3,724 2,069 (2,286) 14
Balance, beginning of period (in shares) at Dec. 31, 2023   10,000,106          
Balance, beginning of period at Dec. 31, 2023 18,165 $ 5,084 7,747 5,496 2,113 (2,286) 11
Increase (Decrease) in Stockholders' Equity              
Net (loss) earnings (1,550)     (1,772)     222
Foreign currency translation adjustments, net of taxes of $0 (22)       (22)    
Distributions to non-controlling interests (219)           (219)
Share-based compensation 46   46        
Issuance of common stock for restricted stock units vested (in shares)   27,984          
Issuance of common stock for restricted stock units vested 0 $ 14 (14)        
Retirement plans:              
Amortization of accumulated other comprehensive gain into net periodic benefit cost, net of taxes of $0 (22)       (22)    
Balance, end of period (in shares) at Mar. 31, 2024   10,028,090          
Balance, end of period at Mar. 31, 2024 16,398 $ 5,098 7,779 3,724 2,069 (2,286) 14
Balance, beginning of period (in shares) at Sep. 30, 2024   10,028,090          
Balance, beginning of period at Sep. 30, 2024 13,062 $ 5,098 7,690 595 1,943 (2,286) 22
Increase (Decrease) in Stockholders' Equity              
Net (loss) earnings (3,126)     (3,124)     (2)
Foreign currency translation adjustments, net of taxes of $0 90       90    
Share-based compensation 129   129        
Issuance of common stock for restricted stock units vested (in shares)   25,444          
Issuance of common stock for restricted stock units vested 0 $ 13 (13)        
Retirement plans:              
Amortization of accumulated other comprehensive gain into net periodic benefit cost, net of taxes of $0 0            
Balance, end of period (in shares) at Mar. 31, 2025   10,053,534          
Balance, end of period at Mar. 31, 2025 10,155 $ 5,111 7,806 (2,529) 2,033 (2,286) 20
Balance, beginning of period (in shares) at Dec. 31, 2024   10,053,534          
Balance, beginning of period at Dec. 31, 2024 11,305 $ 5,111 7,746 (1,322) 2,036 (2,286) 20
Increase (Decrease) in Stockholders' Equity              
Net (loss) earnings (1,207)     (1,207)     0
Foreign currency translation adjustments, net of taxes of $0 (3)       (3)    
Share-based compensation 60   60        
Retirement plans:              
Amortization of accumulated other comprehensive gain into net periodic benefit cost, net of taxes of $0 0            
Balance, end of period (in shares) at Mar. 31, 2025   10,053,534          
Balance, end of period at Mar. 31, 2025 $ 10,155 $ 5,111 $ 7,806 $ (2,529) $ 2,033 $ (2,286) $ 20